Antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus patients with and without nephropathy

North American Journal of Medical Sciences

Volumn 5, Issue 3, 2013, Pages 213-219

  Kumawat, Manjulata ^a   Sharma, Tarun Kumar ^a   Singh, Ishwar ^a   Singh, Neelima ^b   Ghalaut, Veena Singh ^a   Vardey, Satish Kumar ^c   Shankar, Vijay ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b G R MEDICAL COLLEGE   (India)

^c Department of Biochemistry   (India)

Author keywords

Antioxidant enzymes; Glycosylated hemoglobin and diabetic nephropathy; Lipid profile; Malondialdehyde; Non insulin dependent diabetes mellitus; Reduced glutathione

Indexed keywords

ALBUMIN; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PEROXIREDOXIN 5; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; DISEASE ACTIVITY; FEMALE; HUMAN; KIDNEY DISEASE; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; UREA BLOOD LEVEL;

EID: 84875360163     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.109193     Document Type: Article

References (50)

1. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30:1191-212.
2. Waggiallah H, Alzohairy M. The effect of oxidative stress on human red cells glutathione peroxidase, glutathione reductase level, and prevalence of anemia among diabetics. N Am J Med Sci 2011;3:344-7.
3. Lennon SV, Martin SJ, Cotter TG. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 1991;24:203-14.
4. Evans MD, Cooke MS. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays 2004;26:533-42.
5. Lelli JL, Becks LL, Dabrowska MI, Hinshaw DB. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radic Biol Med 1998;25:694-702.
6. Lee YJ, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1998;274:19792-8.
7. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000;404:787-90.
8. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 1999;48:1-9.
9. Wolff SP. Diabetes mellitus and free radicals. Free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993,49:642-52.
10. Jennings PE, Barnett AM. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabet Med 1998;5:111-7.
11. Sinclair AJ. Free radical mechanisms and vascular complications of diabetes mellitus. Diabetes Rev 1993;2:7-10.
12. Barnett AH. Pathogenesis of diabetic microangiopathy: An overview. Am J Med 1991;90:67S-73.
13. Wolf G, Thaiss F. Hyperglycemia-pathophysiological aspects at the cellular level. Nephrol Dial Transplant 1995;10:1109-12.
14. Ha H, Kim KH. Role of oxidative stress in the development of diabetic nephropathy. Kidney Int 1995;48:18-21.
15. Silvio EI. Diabetes Facts and Guidelines. From: American Diabetes Association. Diabetes Care 2010;33:S62.
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP): Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (ATP III). JAMA 2001;285:2486-97.
17. Wolf HU, Lang W, Zander R. Alkaline haematin D-575, a new tool for the determination of hemoglobin as an alternative to the cyanhemoglobin method. Clin Chim Acta 1984;136:83-104.
18. Knowles WJ, Haigh WB, Michaud GC. A monoclonal antibody-based immunoassay for hemoglobin A1c. Diabetes 1986;35 (94A).
19. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-7.
20. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
21. Hafeman DG, Sunde RA, Hoekstra WG. Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J Nutr 1974;104:580-7.
22. Horn HD. Glutathione reductase. In: Bergmayer HU, editor. Method in Enzymatic Analysis. New York: Academic Press; 1963. p. 875-9.
23. Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972;47:389-94.
24. Mishra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
25. Jean CD, Maryse T, Marie JF. Plasma malondialdehyde levels during myocardial infarction. Clin Chim Acta 1983;129:319-22.
26. West IC. Radical and oxidative stress in diabetes. Diabet Med 2000;17:171-80.
27. Jakus V. The role of free radicals, oxidative stress and antioxidant systems in diabetic vascular disease. Bratisl Lek Listy 2000;101:541-51.
28. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet Med 1997;14:45-9.
29. Yan HD, Li XZ, Xie JM, Li M. Effects of advanced glycation end products on renal fibrosis and oxidative stress in cultured NRK-49F cells, Chin Med (Engl) J 2007;120:787-93.
30. Yoshida SI, Hashimoto T, Kihara M, Imai N, Nomura K, Hirawa N, et al. Urinary oxidative stress markers closely reflect the efficacy of Candesartan treatment for diabetic nephropathy. Nephron Exp Nephrol 2008;111:20-30.
31. Ibrahim S, Laila R, Sawsan F. Evaluation of renal gene expression of protein kinase C isoforms in diabetic and non-diabetic proliferative glomerular diseases. Sci World J 2008;31:835-44.
32. Miyata T, Dan T. Inhibition of advanced glycation end products. An implicit goal for the treatment of diabetic nephropathy. Diabetes Res Clin Pract 2008;13:82-6.
33. Forbes JM, Fukami K, Cooper ME. Diabetic nephropathy: Where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes 2007;115:69-84.
34. Kedziora-Kornatowska KZ, Luciak M, Blaszczyk Y, Pawlak W. Effect of aminoguanidin on erythrocyte lipid peroxidation and activities of antioxidant enzymes in experimental diabetes. Clin Chem Lab Med 1998;36:771-5.
35. Ha H, Lee H. Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology 2005;10:7-10.
36. Morsy MD, Hassan WN, Zalat IS. Improvement of renal oxidative stress markers after ozone administration in diabetic nephropathy in rats. Diabetol Metab Syndr 2010;2:29-35.
37. Giugliano D, Cerielo A, Paolisso G. Oxidative stress and diabetic complication. Diabetes Care 1996;19:257-67.
38. Sardi JO. Oxidative stress in diabetes and periodontitis. N Am J Med Sci 2013;5:58-9.
39. Pendyala G, Thomas B, Joshi SR. Evaluation of total antioxidant capacity of saliva in Type 2 diabetic patients with and without periodontal disease: A case-control study. N Am J Med Sci 2013;5:51-7.
40. Bhatia S, Shukla R, Vonkata MS, Kaur GJ, Madhava PK. Antioxidant status, lipid peroxidation and nitric oxide and products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 2003;36:557-62.
41. Blum J, Fridovich I. Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 1985;240:500-8.
42. Sundaram RK, Bhaskar A, Vijayalingam S, Vswanathan M, Mohan R, Shanmuga Sundaram KR. Antioxidants status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 1996;90:255-60.
43. Arai K, Lizuka S, Tada Y, Oikawa K, Taniguelui N. Increase in the glycosylated form of erythrocyte Cu Zn SOD in diabetes and association of non-enzymatic glycosylation with enzyme activity. Biochim Biophys Acta 1987;924:292-6.
44. Selvam R, Anuradha CV. Lipid peroxidation and antiperoxidative enzyme changes in erythrocytes in diabetes mellitus. Indian J Biochem Biophys 1998;25:268-72.
45. Tilton WM, Seaman C, Carriero D, Piomelli S. Regulation of glycolysis in the erythrocyte: Role of the lactate/pyruvate and NAD/NADH ratios. J Lab Clin Med 1991;118:146-52.
46. Kesavulu MM, Giri R, Kameswara Rao B, Apparao C. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications. Diabetes Metab 2000;26:387-92.
47. Slatter DA, Bolton CH, Bailey AJ. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia 2000;43:550-7.
48. Attman PO, Knight-Gibson C, Tavella M, Samuelsson O, Alaupovic P. The compositional abnormalities of lipoproteins in diabetic renal failure. Nephrol Dial Transplant 1998;13:2833-41.
49. Bonnet F, Cooper ME. Potential influence of lipids in diabetic nephropathy: Insights from experimental data and clinical studies. Diabetes Metab 2000;26:254-64.
50. Martinez-Castelao A, Ramos R, Gonzalez MT, Castineira MJ. Dyslipidemia and cardiovascular risk factors in type 2 diabetes mellitus patients with associated diabetic nephropathy. Nefrologia 2002;22:51-8.